StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Damn

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Jul 19, 2021 2:19pm

130 Views

Post# 33570005

RE:RE:RE:RE:Damn

Indeed it is too low - cash on hand alone makes this much higher and this company does have a profile out there linked to the likes of Rexall and other players. CARE/AVRT will be the real story to unfold here with Aristotle at the helm for detection. Market down days like this are not suitable for judgement of any stock (TSX down 345 pts now). We will have good revenue numbers on August 16 and I expect an update on CARE - bother of these factors should illustrate that .40 cents is an insult.

There are so many mindless bashers here trying their best to drive the sp even lower so they can buy in - they are so transparent yet think they are fooling everyone.